Scientific approach to the treatment of vulgaris

Acne vulgaris is a dermatosis which involves the pilosebaceous apparatus of the skin; namely, the and hair follicle (Fig. 1). Wilma F. Bergfeld, M.D Clinically, the skin changes are those of increased

Department of Dermatology numbers of comedones (blackheads), milia (white- Department of Pathology heads or closed comedones), inflammatory papulo- pustular lesions, , and atrophic or hyper- trophic scars. These acne lesions are most fre- quently observed on the face and less frequently on the chest and back. This distribution follows the embryonic development of the sebaceous gland with the greater number of glands being distributed over the face and lesser number and smaller glands distributed over the scalp, chest, and trunk. Acneform lesions may involve other areas such as arms, legs, and intertriginous skin. Acne vulgaris has been associated with other dis- eases of the pilosebaceous apparatus such as seborrheic dermatitis of the face and scalp, dis- secting of the scalp, and suppurativa predominately of the axilla and groin.1 Recognition and treatment of these asso- ciated entities result in concomitantly good re- sponse to therapy. The onset of acne vulgaris is usually associated with the increased androgen stimulation of the sebaceous follicle which occurs either prepuber- tally or at puberty. Acneform lesions develop in

277

Downloaded from www.ccjm.org on September 27, 2021. For personal use only. All other uses require permission. 278 Cleveland Clinic Quarterly Vol. 42, No. 1

SEBACEOUS FOLLICLE

SEBACEOUS GLAND HAIR

DERMIS

PILOSEBACEOUS APPARATUS Fig. 1. Drawing shows pilosebaceous apparatus of the skin.

42% of girls and 36% of boys between lesions develop.3 The inflammatory the ages of 8 and 10 years,2 and in the lesions, papulopustular and cystic, remainder of the adolescent group produce moderate to severe destruc- acneform lesions develop between the tion of the dermis of the skin which ages of 10 and 15 years. Acne vulgaris, eventuates in scarring of the involved a disease of the adolescent, is relatively area (Table 1). Both the inflammatory self-limited, but on occasion it will lesion and the scar are unacceptable to continue into adulthood. the young adolescent. Good results can Clinically, acne vulgaris can be be obtained by removing the primary divided into two major types: inflam- lesions by mechanical extraction and matory and noninflammatory. The acne surgery, which prevent the for- noninflammatory lesions, the come- mation of the more severe inflamma- done and milium, are primary lesions tory acne lesions. of acne from which the inflammatory Pathogenesis of acne

Table 1. Classification of acne The pathogenesis of an acne lesion is influenced by many factors. How- Type of acne Severity ever, the major, local etiologic factors involve the pilosebaceous apparatus. Noninflammatory Minor These are (1) abnormal keratinization Comedones 4 6 Milia of the sebaceous follicle, " (2) the 7 11 Inflammatory Intermediate presence of microflora, " which pro- Papulopustular Moderate duce a lipase capable of breaking down Cystic Moderate-severe the normally secreted sebum into a Cystic-erosive n 12 short-chain fatty acid, C10 to C18 '

Downloaded from www.ccjm.org on September 27, 2021. For personal use only. All other uses require permission. Winter 1975 Treatment of acne vulgaris 279

Abnormal Follicular Keratinization

Microflora Sebum

Fig. 2. Diagram shows factors that influence the pathogenesis of acne.

(Fig. 2). This fatty acid is extremely triglycerides, and less important irritating to the surface of the skin and squalene. has been known to cause an irritant The inflammatory lesions observed reaction when released into the dermis, under light microscopy develop from resulting in an inflammatory acne the leakage of horny materials, fatty lesion (Table 1). acids, and microflora into the support- The keratinizing epithelium of the ing connective tissue and dermis, with sebaceous follicle demonstrates in- a resulting intense inflammatory reac- creased rate of keratinization of cohe- tion composed of polymorphic leuko- sion of the horn cells. This cohesive- cytes, macrophages, giant cells, tissue ness reduces normal shedding and necrosis, and later fibrosis. The forms an impaction (open or closed) greatest amount of fibrosis and necrosis comedone. The impaction can be ex- is in the acne vulgaris major type and aggerated by stomal edema which is results in atrophic or hypertrophic frequently seen in the premenstrual scars on healing. female. The microflora cultured from the Therapeutic approaches keratogenous debri (horn) are Coryne- The therapy of acne vulgaris is bacterium acnes, the most prominent directed toward the known etiologic and important organism, staphylococci factors and occasionally to the lesser (12 varieties), and Pityrosporum ovale contributing factors. The major fac- and orbicularis. The latter two aerobes tors are again abnormal keratiniza- are found in superficial portions of the tion and microflora with lipase activi- infundibulum of the follicle; the an- ties which produce an irritating aerobic diphtheroid, C. acnes, is found short-chain sebum lipid (Table 2). colonized between the lamellar con- The primary acne lesions, come- centric rings of the horny material done and milium, result from abnor- within the comedone. All of these mal keratinization of sebaceous follicle organisms demonstrate a lipase activity and can easily be removed by mechani- which is capable of splitting the lipid cal extraction. This technique can be sebum into short-chain fatty acids, taught to patients so that it can be

Downloaded from www.ccjm.org on September 27, 2021. For personal use only. All other uses require permission. 280 Cleveland Clinic Quarterly Vol. 42, No. 4

Table 2. Treatment of acne vulgaris agents; and salicylic acid prepara- tions.15 Precipitated sulfur solutions Acne minor Topical agents should be avoided since they are 16 Lipid surfactants mildly comedogenic. Vitamin A acid 0.05% to 0.1% cream, The reduction of the normal micro- 0.25% gel flora and the lipase activity of these Acne surgery organisms is extremely helpful in con- Ultraviolet light Drying-oxidizing agents : benzoyl perox- trolling inflammatory acne, intermedi- ide ate and major types. This can be done Antiseborrheic shampoo by topical and systemic therapy. Topi- Acne intermediate cal therapy includes antibiotic solu- Minor + tion, 2% erythromycin alcohol solu- Topical antibiotic solution Parenteral maintenance antibiotics tion, which has been clinically effective 17 (TCN) in reducing the inflammatory lesion; Cryotherapy benzoyl peroxide, an oxidizing agent, Acne major has also been a successful topical Minor + intermediate + agent. The action of the latter ap- Corticosteroids, parenteral Cryotherapy—selected cases pears to dry and oxidize the inflamma- Avoidance of ultraviolet light tory lesion and destroys the anaerobic lipase producer or C. acnes. Since the done at home. By eliminating the pri- C. acnes is the most significant lipase mary lesion one prevents the forma- producer in the inflammatory lesion, tion of an inflammatory acne lesion, control of the number and the lipase papulopustular or cystic.13 Another activity of this diphtheroid definitely topical agent that removes the primary improves the acneform eruption. lesion is vitamin A acid (0.05% to Tetracyclines, erythromycin, and 0.1%) in an alcohol wipe or cream. minocycline administered parenterally This agent, when applied to the skin are also effective agents in treating the daily, reduces the abnormal keratiniza- inflammatory acne of intermediate to tion occurring in the sebaceous follicle, major types.18-20 These antibiotics and thus prevents the formation of reduce the lipase activity and coloni- comedones and milia.14 It is not zation of the microflora even when particularly effective against the in- administered in 50- to 250-mg mainte- flammatory lesions. Vitamin A has nance doses daily.19 Tetracyclines ad- long been used parenterally in doses of ministered to adolescents younger 50,000 to 100,000 I.U. daily for treat- than age 11 is contraindicated because ment of acne vulgaris minor type. This of permanent discoloration of the sec- has been clinically helpful, but double- ondary teeth. blind studies have not supported the Since the evolution of the acneform clinical impression.2 lesion is indirectly related to the size Irritating acnegenic surface lipids and function of the sebaceous gland of the skin may be removed by topical and its production of sebum, it is pos- use of lipid solvents; cleansing agents, sible to control acne vulgaris by con- in the form of soaps, detergents, astrin- trolling the sebaceous gland and its gents, nonionic solutions, abrasive sebum production. This has been

Downloaded from www.ccjm.org on September 27, 2021. For personal use only. All other uses require permission. Winter 1975 Treatment of acne vulgaris 281 done effectively by the use of estrogen Table 3. Precipitating factors, agents products parenterally, which appear to inhibit the androgen stimulation of Hormones (androgen) the sebaceous gland.21-23 The most Hereditary Topical irritants, soaps, precipitated sulfur commonly used estrogen products are coal tar, chlorinated hydrocarbons easily obtained as birth control pills, Systemic drugs, halogens, high dose steroids diethylstilbestrol and Premarin. In Physical agents, cobalt therapy selecting a particular estrogen product, Tissue edema Anxiety-tension state one should avoid those with moderate Diet (controversial) amounts of progesterone24 or androgen derivatives, since these two agents ap- pear to have acnegenic properties. gen therapy is seldom used today be- Diuretics can be used as adjunctive cause of severe postradiation changes therapy for girls and young women if that occur some 20 years after treat- moderate premenstrual tension and ment. It was an effective agent tissue edema are noted. By reducing mainly in treating cystic acne vul- the tissue edema one indirectly re- garis.26 Today, however, ultraviolet duces the impaction of the sebaceous light of suberythema dosage is effec- follicles. tive in reducing comedone and in- Corticosteroids given parenterally flammatory acne. It appears to de- have been especially helpful in con- crease the synthesis of DNA in the trolling the major types of inflamma- keratinizing epithelium and inhibits tory acne. The mechanism of action vascular leakage and stomal inflamma- is their anti-inflammatory qualities tion. Cryotherapy, carbon dioxide rather than a direct action on the slush, or liquid nitrogen have been sebaceous gland or its follicle or both. used in treating the intermediate and Systemic steroids are effective under major types of pustular and cystic the equivalent dose of 20 mg/day of acne. Clinically, this treatment reduces prednisone. A larger dose results in ab- the cutaneous , hastens normal keratinization of the sebaceous the healing of the larger acneform follicle, comedone formation, and lesions, and reduces the late fibrosis .25 Topical steroids, espe- and scarring of the skin (Table 3). cially the hydrocortisone hydrophilic creams, are effective as anti-inflamma- Summary tory agents and can be used sparingly Acne vulgaris, a common dermatosis and infrequently. The fluorinated of the adolescent, is initiated by andro- topical corticosteroids often produce a gen stimulation of the pilosebaceous resistant acneform eruption which is apparatus; namely, the sebaceous extremely difficult to treat. gland and sebaceous follicle. The A variety of physical agents have major etiologic, acnegenic changes are been used in treating and controlling the abnormal keratinization of the acne vulgaris of minor, intermediate, sebaceous follicle, and aerobic and and major types. These agents have anaerobic microflora which produce a been mainly ultraviolet light, cryo- lipase capable of breaking down sebum therapy, and roentgen therapy. Roent- into irritating acnegenic surface lipids.

Downloaded from www.ccjm.org on September 27, 2021. For personal use only. All other uses require permission. 282 Cleveland Clinic Quarterly Vol. 42, No. 1

By directing treatment of acne vul- Topical vitamin A acid in acne vulgaris. garis toward these specific entities, the Arch Dermatol 99: 469-476, 1969. patient can be greatly improved if not 15. Mills OH Jr, Kligman AM, Stewart K: The clinical effectiveness of topical totally cleared of the acneform erup- erythromycin in acne vulgaris. Cutis 15: tion. By attempting treatment of these 93-96, 1975. adolescents at an early age, one reduces 16. Mills OH Jr, Kligman AM: Is sulphur the development of inflammatory helpful or harmful in acne vulgaris? Br lesions and subsequent scarring. J Dermatol 86: 620-627,1972. 17. Cunliffe WJ, Forster RA, Greenwood ND, et al: Tetracycline and acne vulgaris; a References clinical and laboratory investigation. Br Med J 4: 332-335, 1973. 1. Kligman AM: An overview of acne. J 18. Crounse RG: The response of acne to Invest Dermatol 62: 268-287, 1974. placebos and antibiotics. JAMA 193: 906- 2. Burton JL, Cunliffe WJ, Stafford I, et al: 910, 1956. The prevalence of acne in adolescence. 19. Mills OH Jr, Marples RR, Kligman AM: Br J Dermatol 85: 119-126, 1971. Acne vulgaris; oral therapy with tetra- 3. Smith MA, Waterworth PM: The role of cycline and topical therapy with vitamin comedones in acne vulgaris. Br J Dermatol A. Arch Dermatol 106: 200-203, 1972. 54: 337-338, 1962. 20. Hassing GS: Inhibition of Corynebacte- 4. Vasarinsh P: Keratinization of pilar struc- rium acnes lipase by tetracycline. J Invest tures in acne vulgaris and normal skin. Br Dermatol 56: 189-192, 1971. J Dermatol 81: 517-524, 1969. 21. Jarrett A: The effects of stilboestrol on the 5. Knirlson DD: Ultrastructural observations surface sebum and upon acne vulgaris. Br in acne vulgaris; the normal sebaceous J Dermatol 67: 166-179, 1955. follicle and acne lesions. J Invest Dermatol 22. Pochi PE, Strauss JS: Effect of cyclic 62: 288-307, 1974. administration of conjugated equine estro- 6. Plewig G: Follicular keratinization. J In- gens on sebum production in women. J vest Dermatol 62: 308-315,1974. Invest Dermatol 47: 582-585, 1966. 7. Marples RR, McGinley KJ, Mills OH: 23. Strauss JS, Kligman AM, Pochi PE: The Microbiology of comedones in acne vul- effect of androgens and estrogens on garis. J Invest Dermatol 60: 80-83, 1973. human sebaceous glands. J Invest Der- 8. Weary PE: Comedogenics potential of the matol 39: 139-155, 1962. lipid extract of pityrosporum ovale. Arch 24. Strauss JS, Kligman AM: The effect of Dermatol 102: 84-91, 1970. progesterone and progesterone-like com- 9. Marples RR, Izumi AK: Bacteriology of pounds on the human sebaceous gland. pustular acne. J Invest Dermatol 54: 252- J Invest Dermatol 36: 309-319, 1961. 255, 1970. 25. Strauss JS, Pochi PE: The human seba- 10. Marples RR, Kligman AM, Lantis LR, et ceous gland; its regulation by steroidal al: The role of the aerobic microflora in hormones and its use as an end-organ for the genesis of fatty acids in human sur- assaying androgenicity in vivo. Recent face lipids. J Invest Dermatol 55: 173-178, Prog Horm Res 19: 385-444, 1963. 1970. 26. Strauss JS, Kligman AM: Effect of x-rays 11. Kellum RE: Short chain fatty acids (below on sebaceous glands of the human face;

C,=) of human skin surface lipids. J Invest radiation therapy of acne. J Invest Der- Dermatol 48: 364-371, 1967. matol 33: 347-356, 1959. 12. Kligman AM, Wheatley VR, Mills OH: Comedogenicity of human sebum. Arch Additional references Dermatol 102: 267-275, 1970. Robinson HM Jr: Role of antibiotics in 13. Lowney ED, Witkowski J, Simons HM, therapy of acne. Arch Dermatol 69: 414- et al: Value of extraction in 417, 1954. treatment of acne vulgaris. JAMA 189: Wallman IS, Hilton HB: Teeth pigmentation 1000-1002, 1964. by tetracycline. Lancet 1: 827-829, 1962. 14. Kligman AM, Fulton JE Jr, Plewig G: Marples RR, Doroning DT, Kligman AM: In-

Downloaded from www.ccjm.org on September 27, 2021. For personal use only. All other uses require permission. Winter 1975 Treatment of acne vulgaris 283

fluence of pityrosporum species in genera- Freinkel RK: Current concepts; pathogenesis tion of free fatty acids in human surface of acne vulgaris. N Engl J Med 280: 1161- lipids. J Invest Dermatol 58: 158-159, 1972. 1163, 1969. Marples RR: The microflora of the face and Fulton JE Jr, Plewig G, Kligman AM: Effect acne lesions. J Invest Dermatol 62: 326-331, of chocolate on acne vulgaris. JAMA 210: 1974. 2071-2074, 1969. Emerson GW, Strauss JS: Acne and acne care. Hecht H: Hereditary trends in acne vul- Arch Dermatol 105: 407-411, 1972. garis. Dermatologica 121: 297-307, 1960.

Downloaded from www.ccjm.org on September 27, 2021. For personal use only. All other uses require permission.